85.03 0.00 (0.00%)
After hours: 4:15PM EDT
|Bid||85.06 x 800|
|Ask||85.09 x 800|
|Day's Range||84.62 - 87.34|
|52 Week Range||61.05 - 88.48|
|Beta (3Y Monthly)||1.09|
|PE Ratio (TTM)||28.46|
|Earnings Date||Oct 24, 2019|
|Forward Dividend & Yield||0.88 (1.01%)|
|1y Target Est||92.60|
Edwards Lifesciences (EW) initiated the Field Corrective Action after receiving reports of 17 injuries and a death from the use of the Sapien 3 Ultra delivery system.
Zimmer Biomet's (ZBH) AVBT solution, The Tether, uses a solid, flexible cord in place of traditional metal rods to pull on the outside of a scoliosis curve.
Robust domestic sales along with a strong unveiling of the t:slim X2 Insulin Pump in the international markets augur well for Tandem Diabetes (TNDM).
With the FDA's expanded indication nod, Medtronic's (MDT) Evolut TAVR platform now comes in handy for treating symptomatic severe aortic stenosis patients across all risk categories.
McKesson (MCK) is gaining from strong segmental performance and solid prospects in the pharmaceutical and medical supplies distribution market.
This regulatory approval is expected to strengthen Restoration Robotics' (HAIR) hair restoration business and expand its presence globally.
The Baxter International Foundation, the philanthropic arm of Baxter International Inc. (BAX), and the global humanitarian organization Direct Relief announced today the launch of the Transformative Innovation Awards for Community Health: Incorporating Nutrition to Improve Diabetes Health Outcomes. The three-year program will award $750,000 in funding to health centers and free and charitable clinics that are working to improve diabetes health outcomes for patients, focusing on the Greater Chicago area in the first year. “Ensuring that individuals from all communities and neighborhoods have access to needed health resources is one of the reasons that we partner with companies like Baxter,” said Thomas Tighe, president and CEO, Direct Relief.
Nevro (NVRO) is gaining traction from a fortified international footprint and solid prospects in the SCS market. However, stiff competition remains a woe.
Wright Medical (WMGI) continues to benefit from strong international sales, new product launches and solid prospects in the global Orthopedic space. However, forex remains a woe.